10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,774,532 | +80.7% | 503,625 | +144.7% | 0.01% | +75.0% |
Q2 2023 | $11,493,869 | +609.1% | 205,807 | +608.3% | 0.00% | +300.0% |
Q1 2023 | $1,620,979 | +420933.5% | 29,055 | +175.0% | 0.00% | – |
Q4 2022 | $385 | -99.9% | 10,567 | -20.0% | 0.00% | – |
Q3 2022 | $377,000 | -75.0% | 13,206 | -60.4% | 0.00% | -100.0% |
Q2 2022 | $1,509,000 | -74.5% | 33,336 | -57.1% | 0.00% | -50.0% |
Q1 2022 | $5,911,000 | -39.9% | 77,728 | +17.8% | 0.00% | -33.3% |
Q4 2021 | $9,832,000 | +5.1% | 65,997 | +2.7% | 0.00% | 0.0% |
Q3 2021 | $9,356,000 | -21.5% | 64,265 | +5.5% | 0.00% | -25.0% |
Q2 2021 | $11,926,000 | +100.3% | 60,887 | +84.8% | 0.00% | +100.0% |
Q1 2021 | $5,955,000 | +208.7% | 32,946 | +141.9% | 0.00% | +100.0% |
Q4 2020 | $1,929,000 | +160.0% | 13,622 | +128.9% | 0.00% | – |
Q3 2020 | $742,000 | – | 5,951 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |